Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis -oralis Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-Resistance

By sjmartinez • March 7, 2023

Mishra NN, Abdelhady W, Elsayed AM, Lapitan C, Proctor RA, Rybak MJ, Miro JM, Bayer AS. Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis-oralis Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-Resistance. Antimicrob Agents Chemother. 2023 Mar 6:e0147222. doi: 10.1128/aac.01472-22. Epub ahead of print. PMID: 36877026.

Tags: ceftriaxone, daptomycin, endocarditis, Harbor UCLA, Infectious Diseases, Publications, S. mitis-oralis

Multifactorial causes of severe persistent hypercalcemia in an immunosuppressed woman with chronic kidney disease

Nalluri K, Goodman EL, Pasupneti T, Nunez G, Wang EC. Multifactorial causes of severe persistent hypercalcemia in an immunosuppressed woman with chronic kidney disease. JCEM[...]

Effects of normobaric hypoxia and hyperthermia on ventilatory responses to high-intensity interval training bouts

Girardi M, Nicolò A, Marcora SM, Bazzucchi I, Felici F, Dickinson J, Sacchetti M. Effects of normobaric hypoxia and hyperthermia on ventilatory responses to high-intensity[...]

Agatston-2.0: A next-generation AI-based coronary calcium quantification approach to improve risk stratification among individuals with zero Agatston scores – Part I: An AI-CVD Study within the Multi-Ethnic Study of Atherosclerosis and Framingham Heart Study

Naghavi M, Azimi A, Atlas K, Reeves AP, Zhang C, Mirjalili SR, Mozafarybazargany M, Jolfayi AG, Hashemi A, Atlas T, Wasserthal J, Vliegenthart R, Henschke[...]